Global Giant Cell Arteritis Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Giant Cell Arteritis Treatment Market Research Report 2024
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
According to MRAResearch’s new survey, global Giant Cell Arteritis Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Giant Cell Arteritis Treatment market research.
Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin however, current evidences are mixed. In a large epidemiologic study with a 12-year follow-up, there has been synchronous variation in the incidence of giant cell arteritis with epidemics of Mycoplasma pneumoniae, Chlamydia pneumonia and parvovirus B19.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Giant Cell Arteritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Segment by Type
Corticosteroid Therapy
Adjuvant Agents
Hospitals
Clinics
ASCs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Giant Cell Arteritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Giant Cell Arteritis Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Giant Cell Arteritis Treatment market research.
Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin however, current evidences are mixed. In a large epidemiologic study with a 12-year follow-up, there has been synchronous variation in the incidence of giant cell arteritis with epidemics of Mycoplasma pneumoniae, Chlamydia pneumonia and parvovirus B19.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Giant Cell Arteritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Segment by Type
Corticosteroid Therapy
Adjuvant Agents
Segment by Application
Hospitals
Clinics
ASCs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Giant Cell Arteritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source